Clinical Trial Update: Endothelial Microparticles in Systemic Sclerosis Pulmonary Hypertension

View source ↗

Summary

This clinical trial update indicates the study examining endothelial microparticles in systemic sclerosis-associated pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Systemic Sclerosis, Pulmonary Hypertension | Status: COMPLETED